-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
-
Summary
-
BriaCell Therapeutics Corp. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Jul 2022 to 31 Jan 2026.
- BriaCell Therapeutics Corp. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Jan 2026 was $30,213,808, a 836% increase year-over-year.